Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | -147 | 151 | 436 | 165 | 2,168 |
| Gross Profit | -147 | 151 | 436 | 165 | 14,766 |
| Operating Expenses | 67,238 | 66,028 | 51,352 | 36,867 | 106,723 |
| Operating Income | -67,385 | -65,877 | -50,916 | -36,702 | -104,555 |
| Interest Expense | 2,836 | 2,226 | 2,123 | 1,889 | 6,282 |
| Other Income | 1,439 | 233 | 1,067 | 1,182 | 756 |
| Pre-tax Income | -68,782 | -67,870 | -51,972 | -37,409 | -110,081 |
| Income Tax | -209 | -1,700 | 45 | 18 | -67 |
| Net Income Continuous | -68,573 | -66,170 | -52,017 | -37,427 | -110,014 |
| Minority Interests | -802 | -567 | -578 | -389 | N/A |
| Net Income | $-67,771 | $-65,603 | $-51,439 | $-37,038 | $-107,633 |
| EPS Basic Total Ops | -0.18 | -0.17 | -0.14 | -0.10 | 0.12 |
| EPS Basic Continuous Ops | -0.18 | -0.17 | -0.14 | -0.10 | 0.11 |
| EPS Diluted Total Ops | -0.18 | -0.17 | -0.14 | -0.10 | 0.12 |
| EPS Diluted Continuous Ops | -0.18 | -0.17 | -0.14 | -0.10 | 0.11 |
| EBITDA(a) | $-64,790 | $-61,991 | $-47,370 | $-33,196 | $-97,305 |